Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Pulmonary Consumption

lamivudine has been researched along with Pulmonary Consumption in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Hui, S; Li, Z1
Brophy, JC; Chan, AK; Hawkes, MT; Mateyu, G; Mwinjiwa, E; Sodhi, SK1
Akhavan-Mogaddam, J; Emadi, SE; Emadi, SN; Moshkforoush, A; Sobhani, B; Yousefi, M1
Boom, WH; Charlebois, E; Havlir, DV; Lin, R; Mayanja-Kizza, H; Mugerwa, RD; Mugyenyi, P; Mupere, E; Nanteza, MW; Srikantiah, P; Whalen, CC1
Goliath, R; Meintjes, G; Seldon, R; Wilkinson, KA; Wilkinson, RJ1
Chau, TN; Chiu, MC; Lai, ST; Ng, TK; Tam, CM; Yu, WC1
Friedland, G; Jack, C; Khoo, S; Lalloo, U1
Boom, WH; Charlebois, ED; Havlir, DV; Kayanja, HK; Lin, R; Mayanja-Kizza, H; Mugerwa, RD; Srikantiah, P; Walusimbi, MN; Whalen, CC1

Reviews

1 review(s) available for lamivudine and Pulmonary Consumption

ArticleYear
[Intervention efficacy of lamivudine on liver dysfunction in patients undergoing anti-tuberculosis treatment for pulmonary tuberculosis complicated with 
chronic hepatitis B: a Meta-analysis].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2015, Volume: 40, Issue:8

    Topics: Antitubercular Agents; Antiviral Agents; China; Hepatitis B, Chronic; Humans; Lamivudine; Randomized Controlled Trials as Topic; Treatment Outcome; Tuberculosis, Pulmonary; Viral Load

2015

Trials

1 trial(s) available for lamivudine and Pulmonary Consumption

ArticleYear
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
    The Journal of infectious diseases, 2011, Sep-15, Volume: 204, Issue:6

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; Young Adult; Zidovudine

2011

Other Studies

6 other study(ies) available for lamivudine and Pulmonary Consumption

ArticleYear
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleotides; Female; HIV Infections; HIV Wasting Syndrome; Humans; Infant; Lamivudine; Malawi; Male; Proportional Hazards Models; Retrospective Studies; Rural Population; Stavudine; Survival Analysis; Tuberculosis, Pulmonary; Zidovudine

2016
Extensive hypertrophic lichen planus in an HIV positive patient.
    Dermatology online journal, 2010, Jun-15, Volume: 16, Issue:6

    Topics: Adult; Anti-HIV Agents; Clobetasol; Drug Combinations; Hand Dermatoses; HIV Infections; Humans; Lamivudine; Lichen Planus; Male; Nevirapine; Pruritus; Stavudine; Treatment Outcome; Tuberculosis, Pulmonary

2010
Immunological characterisation of an unmasking TB-IRIS case.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012, Mar-02, Volume: 102, Issue:6

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Cytokines; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Opportunistic Infections; Stavudine; Thymic Factor, Circulating; Tuberculosis, Pulmonary

2012
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2006, Volume: 10, Issue:7

    Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary

2006
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Benzoxazines; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Oxazines; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Viral Load

2006
Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.
    AIDS (London, England), 2007, Sep-12, Volume: 21, Issue:14

    Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Tuberculosis, Pulmonary; Zidovudine

2007